MARATTO

article · Scientific Reports

Fungal-mediated green synthesis of ZnO–MnO nanocomposites with antimicrobial and anticancer properties

2026Open accessMenoufia University

Abstract

The urgent need for sustainable therapeutic nanomaterials has driven interest in green synthesis routes. In this study, zinc oxide-manganese oxide nanocomposites were mycosynthesized by employing the fungal extracellular filtrate of Aspergillus terreus. Characterization based on different spectroscopical analysis confirmed their crystalline structure, associated functional groups, and nanoscale morphology. The obtained composites showed nanoscales with average particle sizes of 75 nm and 99 nm as determined by TEM and DLS analysis, respectively. Additionally, microbiological assays revealed their strong growth-ceasing activity against Escherichia coli and Bacillus subtilis strains. Also, the time-kill assessment demonstrated rapid bacterial reduction at higher nanocomposite doses. Cytotoxicity studies indicated good safety in the case of WI-38 normal cells, potent anticancer activity against the MCF-7 tumor cell line, and a respectable selectivity index approximately 3.4 for the tested cancerous cell line. These findings highlight fungal-mediated biosynthesis as an eco-friendly route for producing zinc oxide-manganese oxide nanocomposites with respected spectrum antimicrobial activity and anticancer potential.

Research topics

  • Nanoparticles: synthesis and applications
  • Geochemistry and Elemental Analysis
  • Microbial Metabolism and Applications

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1038/s41598-026-45546-6

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.